392 related articles for article (PubMed ID: 15193823)
1. Female preponderance in ibutilide-induced torsade de pointes.
Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
[TBL] [Abstract][Full Text] [Related]
2. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
[TBL] [Abstract][Full Text] [Related]
3. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
5. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
[TBL] [Abstract][Full Text] [Related]
6. Ibutilide-induced long QT syndrome and torsade de pointes.
Gowda RM; Punukollu G; Khan IA; Patlola RR; Tejani FH; Cosme-Thormann BF; Vasavada BC; Sacchi TJ
Am J Ther; 2002; 9(6):527-9. PubMed ID: 12424513
[TBL] [Abstract][Full Text] [Related]
7. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
9. The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm.
Sideris S; Bonios M; Melexopoulou C; Exarchos P; Tsatiris K; Kogias J
Cardiology; 2007; 107(4):399-401. PubMed ID: 17284902
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
Tercius AJ; Kluger J; Coleman CI; White CM
Pacing Clin Electrophysiol; 2007 Nov; 30(11):1331-5. PubMed ID: 17976094
[TBL] [Abstract][Full Text] [Related]
11. Ibutilide therapy for atrial fibrillation: 5-year experience in a community hospital.
Giudici MC; Fischer WJ; Cervantes DC; Schrumpf PE; Paul DL; Sentman KE; Serra VL; Barold SS
J Cardiovasc Nurs; 2008; 23(6):484-8. PubMed ID: 18953211
[TBL] [Abstract][Full Text] [Related]
12. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.
Korantzopoulos P; Kolettis TM; Papathanasiou A; Naka KK; Kolios P; Leontaridis I; Draganigos A; Katsouras CS; Goudevenos JA
Heart; 2006 May; 92(5):631-4. PubMed ID: 16159973
[TBL] [Abstract][Full Text] [Related]
13. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and cost analysis of ibutilide.
Dunn AB; White CM; Reddy P; Chow MS; Kluger J
Ann Pharmacother; 2000 Nov; 34(11):1233-7. PubMed ID: 11098333
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
[TBL] [Abstract][Full Text] [Related]
16. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
Johansson M; Carlsson L
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
[TBL] [Abstract][Full Text] [Related]
17. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
18. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
[TBL] [Abstract][Full Text] [Related]
19. Ibutilide (Corvert): suspected association with torsades de pointes.
CMAJ; 2004 Oct; 171(8):994. PubMed ID: 15497210
[No Abstract] [Full Text] [Related]
20. [Iatrogenic torsade de pointes induced by thioridazine].
Paoloni P; Ciliberti D; Blasi N; Capone P
Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
